Engineering and Development

Management and Executive

Legal and Compliance

Customer Service and Support

Chief Financial Officer

Senior Vice President CMC Development

S&P 500's New AI Play? Walmart In Buy Zone, Leads Five Stocks To Watch Amid Volatile Market

Alnylam to Webcast Conference Call Discussing Third Quarter 2025 Financial Results

Cardiovascular Drugs Market Size to Reach US$ 247.8 Billion by 2033, Driven by Rising Cardiovascular Disease Cases and Lifestyle Changes | According to DataM Intelligence

This Pharma Play, The IBD Stock Of The Day, Is Offering Another Entry Amid 100% Advance This Year

Associate Director, Early Development Quality (R&D QA)

Alnylam Pharmaceuticals is a leader in RNAi therapeutics, committed to transforming lives through innovative science. The Early Development Quality Lead will oversee quality for internal and outsourced activities related to nonclinical studies and biomarker utilization, ensuring compliance with regulatory standards and quality systems.

Sign up with Google

Sign in with Google